NOVARTIS AG NAMENS-AKTIEN SF 0,5
NOVARTIS AG NAMENS-AKTIEN SF 0,5/ CH0012005267 /
904278
10/8/2024 5:56:16 PM
|
Chg.
+0.040
|
Volume |
Bid5:56:16 PM |
Ask5:56:16 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
103.220EUR
|
+0.04%
|
- Turnover: - |
103.220Bid Size: - |
104.620Ask Size: - |
236.33 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
7.15 USD |
124.14% |
EPS Diluted: |
- USD |
123.97% |
Revenues per Share: |
20.49 USD |
-14.09% |
Book Value per Share: |
20.49 USD |
-26.91% |
Cash Flow per Share: |
6.35 USD |
227.31% |
Dividend per Share: |
3.90 USD |
4.00% |
Total |
in mill. |
|
Revenues: |
46,660.00 USD |
-7.69% |
Net Income: |
14,850.00 USD |
113.52% |
Operating Cash Flow: |
14,458.00 USD |
- |
Cash and Cash Equivalents: |
13,393.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
15.93 |
14.06 |
P/S Ratio: |
5.56 |
4.91 |
P/BV ratio: |
5.56 |
4.91 |
P/CF Ratio: |
17.94 |
15.84 |
PEG: |
0.13 |
0.11 |
Earnings Yield: |
6.28% |
7.11% |
Dividend Yield: |
3.42% |
3.88% |
Market Capitalization |
|
Market Capitalization: |
236.33 bill. EUR |
207.39 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
3.11 mill. EUR |
2.73 mill. EUR |
Shares Outstanding: |
2.03 bill. |
|
Profitability
Gross Profit Margin: |
73.27% |
EBIT Margin: |
20.94% |
Net Profit Margin: |
31.83% |
Return on Equity: |
31.82% |
Return on Assets: |
14.86% |
Financial Strength
Liquidity I / Cash Ratio: |
50.75% |
Liquidity II / Quick Ratio: |
77.68% |
Liquidity III / Current Ratio: |
115.50% |
Debt / Equity Ratio: |
114.17% |
Dynam. Debt / Equity Ratio: |
368.50% |
Efficiency
Employees: |
76,057 |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
613,487.25 USD |
Net Income / Employee: |
195,248.30 USD |
Total Assets / Employee: |
1,314,080.23 USD |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
IFRS |